Gut Microbiota and Metabolites Mediate Health Benefits of Oat and Oat Bran Consumption in IBD Mice
Nutrients · 18.12.2024 · 16 (24) · 4365
DOI: 10.3390/nu16244365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 18.12.2024. Verfasst von Wen Duan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Sciences and Engineering, South China University of Technology, Guangzhou 510641, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Avena, Dietary Fiber, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Leading Talents Project of Guangzhou Devel-opment Zone, Cornell China Center and YanGuFang Research Laboratory, Innovative Leading Talents Project of Guangzhou Development Zone.
Abstract (Originalsprache)
Background/Objectives: Inflammatory bowel disease (IBD) is a chronic condition influenced by a variety of factors, including genetics, the environment, and gut microbiota. The incidence of IBD is increasing globally. Previous studies have shown that interactions between diet and gut microbiota influence the pathogenesis and treatment of IBD. Proper dietary nutrition including oat and oat bran regulates chronic inflammation, which is essential for individual health, and is one of the essential factors in reducing inflammation in the body and keeping the immune system functioning properly, which plays a role in the prevention and treatment of diseases. However, the mechanism of action of whether oat and oat bran will alleviate chronic inflammation by modulating intestinal flora and metabolites remains unknown.
Methods
Therefore, in this study, we have used a mouse model of dextran sulfate sodium (DSS) chronic colitis to analyze the composition of intestinal microbiota, short-chain fatty acid content, and the expression of the relevant genes.
Results
The results showed that diets supplemented with oat and oat bran improved intestinal barrier parameters, decreased the levels of inflammatory factors, modulated the composition of intestinal microbiota, and increased the content of short-chain fatty acids.
Conclusions
This study provides strong evidence that dietary interventions with oats or oat bran may have potential applications in clinical nutrition and dietary interventions for chronic IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food Sciences and Engineering, South China University of Technology, Guangzhou 510641, China.
- Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health, School of Food Sciences and Engineering, South China University of Technology, Guangzhou 510641, China.
- Department of Food Science, Cornell University, Ithaca, NY 14853, USA.
ORCID-Profile: Bisheng Zheng
Förderung
- Innovative Leading Talents Project of Guangzhou Devel-opment Zone
- Cornell China Center and YanGuFang Research Laboratory
- Innovative Leading Talents Project of Guangzhou Development Zone
Zitieren
APA
Duan, W., Zheng, B., Li, T., & Liu, R. (2024). Gut Microbiota and Metabolites Mediate Health Benefits of Oat and Oat Bran Consumption in IBD Mice. Nutrients, 16(24), 4365. https://doi.org/10.3390/nu16244365
Vancouver
Duan W, Zheng B, Li T, Liu R. Gut Microbiota and Metabolites Mediate Health Benefits of Oat and Oat Bran Consumption in IBD Mice. Nutrients. 2024;16(24):4365. doi:10.3390/nu16244365
BibTeX
@article{Duan2024,
author = {Duan, Wen and Zheng, Bisheng and Li, Tong and Liu, Ruihai},
title = {Gut Microbiota and Metabolites Mediate Health Benefits of Oat and Oat Bran Consumption in IBD Mice},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {24},
pages = {4365},
doi = {10.3390/nu16244365}
}
EUVIMED